As of 2024-12-12, the Relative Valuation of Medmix Ltd (MEDX.SW) is 3.19 CHF. This relative valuation is based on P/E multiples. With the latest stock price at 8.79 CHF, the upside of Medmix Ltd based on Relative Valuation is -63.7%.
The range of the Relative Valuation is (0.96) - 8.17 CHF.
| Range | Selected | |
| Trailing P/E multiples | 21.8x - 35.5x | 31.2x |
| Forward P/E multiples | 34.7x - 40.7x | 38.7x |
| Fair Price | (0.96) - 8.17 | 3.19 |
| Upside | -110.9% - -7.0% | -63.7% |
| Date | P/E |
| 2024-11-29 | -194.88 |
| 2024-11-28 | -192.61 |
| 2024-11-27 | -192.61 |
| 2024-11-26 | -194.20 |
| 2024-11-25 | -198.05 |
| 2024-11-22 | -196.01 |
| 2024-11-21 | -195.79 |
| 2024-11-20 | -201.45 |
| 2024-11-19 | -205.76 |
| 2024-11-18 | -208.02 |
| 2024-11-15 | -211.87 |
| 2024-11-14 | -214.37 |
| 2024-11-13 | -213.91 |
| 2024-11-12 | -213.01 |
| 2024-11-11 | -226.38 |
| 2024-11-08 | -220.03 |
| 2024-11-07 | -221.17 |
| 2024-11-06 | -211.65 |
| 2024-11-05 | -211.19 |
| 2024-11-04 | -216.41 |
| 2024-11-01 | -222.07 |
| 2024-10-31 | -224.79 |
| 2024-10-30 | -225.02 |
| 2024-10-29 | -227.51 |
| 2024-10-28 | -225.92 |
| 2024-10-25 | -223.43 |
| 2024-10-24 | -225.47 |
| 2024-10-23 | -222.98 |
| 2024-10-22 | -225.02 |
| 2024-10-21 | -227.96 |
| 2024-10-18 | -225.92 |
| 2024-10-17 | -219.35 |
| 2024-10-16 | -224.34 |
| 2024-10-15 | -227.96 |
| 2024-10-14 | -232.95 |
| 2024-10-11 | -231.14 |
| 2024-10-10 | -235.21 |
| 2024-10-09 | -232.50 |
| 2024-10-08 | -231.59 |
| 2024-10-07 | -235.67 |
| 2024-10-04 | -235.67 |
| 2024-10-03 | -228.87 |
| 2024-10-02 | -227.96 |
| 2024-10-01 | -227.06 |
| 2024-09-30 | -234.31 |
| 2024-09-27 | -235.67 |
| 2024-09-26 | -230.68 |
| 2024-09-25 | -222.98 |
| 2024-09-24 | -218.45 |
| 2024-09-23 | -215.27 |